[Primary study on immunologic effect of live attenuated hepatitis A vaccine (H2 strain) after booster dose]

Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Apr;21(2):124-7.
[Article in Chinese]

Abstract

Objective: To study the immunologic effect of live attenuated hepatitis A vaccine (H(2) Strain, 10(7.0)TCID(50)) after booster and to compare with the results of 1 dose live attenuated hepatitis A vaccine (H(2) Strain, 10(7.0)TCID(50)).

Methods: 42 susceptibles with negative anti - HAV were selected in Zhengding, Hebei province. Each subject received 3 doses live attenuated hepatitis A vaccine at 0, 2, 6 months and was bled at 1, 2, 6, 7, 9, 12 months after vaccination.

Results: The seroconversion rate at 1 month after the first dose was 81.4% and reached 100% after the second dose. GMT arrived the peak 2,739 mIU/ml at one month after the third dose, before stared declining. The seroconversion rate kept 100% at 12 months after the first dose, but GMT decreased to 979 mIU/ml.

Conclusion: The first dose worked as the base of boostering. A booster dose of live attenuated hepatitis A vaccine could induce secondary immune response well. The immunologic effect after booster dose could match the effect with inactivated vaccine and was better than the results of 1 dose live attenuated hepatitis A vaccine. The program seemed to be useful to the protective effect and the immuno - persistence.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Female
  • Hepatitis A Vaccines / immunology*
  • Hepatitis Antibodies / blood
  • Humans
  • Immunization, Secondary
  • Male
  • Vaccines, Inactivated / immunology

Substances

  • Hepatitis A Vaccines
  • Hepatitis Antibodies
  • Vaccines, Inactivated